Blue Cross and Blue Shield of North Carolina Expands Specialty Pharmacy Precertification List (Healthy Blue + Medicare (HMO D-SNP))

April 29, 2024
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Blue Medicare
media-label
label
link
Blue Medicare
icon-position
right
full-width
false
full-width-mobile
false

Please note, this communication applies to Healthy Blue + Medicare℠ (HMO-POS D-SNP) offered by Blue Cross and Blue Shield of North Carolina.

Effective for dates of service on and after August 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.

Federal and state law, as well as state contract language and CMS guidelines – including definitions and specific contract provisions / exclusions – take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

HCPCS or CPT® codes Medicare Part B drugs
J9286 Columvi (glofitamab-gxbm)
C9162, J3490, J3590, J9999 Izervay (avacincaptad pegol)
J9333 Rystiggo (rozanolixizumab-noli)
J9334 Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc)

We look forward to working together to achieve improved outcomes.